CT Zebras

For persons with primary immunodeficiency and those who love them

  • Home
  • Blog Posts
  • Resources
  • Helpful Links
  • Store
  • Contact Us
  • Cookie Policy (US)
You are here: Home / Drugs / Beware of Generics

Beware of Generics

December 9, 2019

An opinion piece in the Washington Post “Generics are cheap and popular, but some might not be as safe as you’d expect” was written by C. Michael White, a professor and head of the Department of Pharmacy Practice at the University of Connecticut. In it, he warns of the number of drugs manufactured overseas, contamination risks, and the lack of direct FDA oversight.

The article is based on an editorial he wrote for Annals of Pharmacotherapy This is a critically important issue, and one for our legislators to examine.

Generic medications become available when the patent runs out on a particular drug. Drug companies sometimes pay the generic manufacturers to delay releasing a generic (less expensive) version of the drug. If the generic manufacturers can make more money by withholding a drug from the market, it makes good business sense. However, maintaining drug prices artificially high hurts everyone.

Most providers allow generic substitutions when they are available and many states require it. About 90% of prescriptions today are available in generic form. Generics cost less, and up to now, were thought to be equivalent to their more-expensive brand name counterparts. Katherine Eban, author of Bottle of Lies spent TEN years investigating the overseas generic manufacturing business and the lack of true FDA oversight. She expresses serious concerns about drugs coming from other countries. The FDA publishes warning letters sent to manufacturers who violate standards for producing these drugs. A private Web site collates these letters and indexes them for easy searching and analysis

Never forget the expert on your health is YOU! If you are taking a generic drug and not getting the results you expect, do some detective work. First, alert your provider that you are concerned about the quality of the generic drug because you are not getting the expected benefit. Next, check with the pharmacy to find out the manufacturer of that particular generic drug. Then, you can look up the company on the FDA Web site to see if there have been warning letters issued. Finally, discuss your concerns with your provider to come up with a plan; the provider’s discussion with the insurance company may allow you to get the brand name drug for safety. If not, you can always appeal with advice from the Connecticut Healthcare Advocate.

Filed Under: Drugs, Generic Tagged With: drug, FDA, generic, medication, overseas

Save the Date!

Next CT Zebras Meeting – Virtual 
We have taken the summer off, and will let you know when our first fall meeting is. We usually meet just after dinner.

Please join us! Our meetings are open to people who are living with primary immune deficiency, are in the process of diagnosis, and the people who love them.

Click here  to sign up and we’ll let you know as soon as we have a date.

 

CT Rare Action Network (CT-RAN)              During the legislative session, advocates from many disease groups meet to discuss legislative priorities and make sure they align. Check back to learn when the meetings will start this fall. All are welcome!

 

The Society for Participatory Medicine - Member

Welcome to the Toronto Zoo

Search site

Recent Posts

  • Will the COVID-19 vaccines work in people with immune suppression?
  • CT Department of Health Vaccine Update
  • Information About Boosters
  • Co-Pay Accumulator is Signed!
  • Get the CT COVID Phone App

Privacy Policy

Click here for our Privacy Policy

Cookie Statement

Click here for cookie statement

Terms and Conditions

For terms and conditions click here

Copyright 2019-2021    @CTZebras

CT Zebras and Patricia Carroll

Copyright © 2023 · Outreach Pro on Genesis Framework · WordPress · Log in

Manage Cookie Consent
We use cookies to optimize our website and our service. By clicking on ACCEPT, you accept  Terms and Conditions
Functional cookies Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}